Literature DB >> 11597729

Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromes.

S Alvi1, A Shaher, V Shetty, B Henderson, B Dangerfield, F Zorat, L Joshi, S Anthwal, L Lisak, L Little, S Gezer, S Mundle, P L Reddy, K Allampallam, X Huang, N Galili, R Z Borok, A Raza.   

Abstract

We used bone marrow biopsies instead of mononuclear cells to maintain long-term cultures from 103 patients belonging to all five sub-categories of myelodysplastic syndromes (MDS), as well as 12 normal controls. By week 4, 30-50% confluency was reached and could be maintained for up to 12 weeks with 100% confluency. The four prominent cells were fibroblasts, macrophages, endothelial cells and adipocytes. Immunohistochemical and electron microscopic studies provided lineage confirmation. Normal hematopoiesis was well supported by MDS stroma. Neither the FAB nor cytogenetics was co-related with the potency of growth. MDS stroma appears to be both morphologically and functionally normal.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597729     DOI: 10.1016/s0145-2126(01)00061-3

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  7 in total

1.  The stromal component of the marrow microenvironment is not derived from the malignant clone in MDS.

Authors:  Aravind Ramakrishnan; Norihiro Awaya; Eileen Bryant; Beverly Torok-Storb
Journal:  Blood       Date:  2006-07-15       Impact factor: 22.113

2.  Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch".

Authors:  Neil E Kay; Tait D Shanafelt; Ann K Strege; Yean K Lee; Nancy D Bone; Azra Raza
Journal:  Leuk Res       Date:  2007-01-22       Impact factor: 3.156

3.  NFĸB Targeting in Bone Marrow Mesenchymal Stem Cell-Mediated Support of Age-Linked Hematological Malignancies.

Authors:  Lauren S Sherman; Shyam A Patel; Marianne D Castillo; Rachel Unkovic; Marcelo Taborga; Marina Gergues; Shaun Patterson; Jean-Pierre Etchegaray; Mohammed Jaloudi; Anupama Hooda-Nehra; Joshua Kra; Darling P Rojas; Victor T Chang; Pranela Rameshwar
Journal:  Stem Cell Rev Rep       Date:  2021-08-19       Impact factor: 5.739

4.  Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.

Authors:  Gergely Varga; Judit Kiss; Judit Várkonyi; Virág Vas; Péter Farkas; Katalin Pálóczi; Ferenc Uher
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

Review 5.  Oxidative stress and the myelodysplastic syndromes.

Authors:  Morag J Farquhar; David T Bowen
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

Review 6.  Beyond the Niche: Myelodysplastic Syndrome Topobiology in the Laboratory and in the Clinic.

Authors:  Eugenia Flores-Figueroa; Dita Gratzinger
Journal:  Int J Mol Sci       Date:  2016-04-13       Impact factor: 5.923

Review 7.  Mesenchymal stromal cells in myeloid malignancies.

Authors:  Thomas Schroeder; Stefanie Geyh; Ulrich Germing; Rainer Haas
Journal:  Blood Res       Date:  2016-12-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.